Delivery Order SPE2DB22D2206-SPE2DB25FJF50
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $37,038 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $41,652.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of September 29, 2025. This competitive award carries no set-aside designation and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $29,356.38 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 13, 2025. This non-competitive delivery order represents a firm fixed price contract executed on November 12, 2025, and is performed from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor and critical federal medical supply vendor,...
- The Defense Logistics Agency awarded a $21,965.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of June 3, 2025. This contract was competitively awarded with no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order falls under...
- The Defense Logistics Agency awarded a $9,253.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial indefinite delivery/indefinite quantity (IDIQ) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $14,002.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 8, 2025. This non-set-aside award was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $16,264.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on October 16, 2025, with an ultimate completion date of October 17, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $15,467.93 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of June 25, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $27,213.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 5, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery will be fulfilled at...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJF50Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,927.95 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply brand-name medications, generic drugs, vaccines, and specialized medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Enbrel, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions, exemplifies the diverse therapeutic portfolio that AmerisourceBergen delivers under this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 8/4/25 |